Diabetes Management
Jacksonville Family Transforms Type 1 Diabetes Diagnosis Into Advocacy Through Community Initiative
A Jacksonville family's journey with their son's Type 1 diabetes diagnosis has evolved into Pablo's Pack T1D, a community initiative providing resources and support while participating in the Breakthrough T1D Walk to advance research toward a cure.
Combining Healthy Lifestyle Habits with GLP-1 Medications Reduces Cardiovascular Risk in Type 2 Diabetes Patients
A study of over 63,000 veterans with Type 2 diabetes found that combining GLP-1 receptor agonist medications with at least six healthy lifestyle habits reduced cardiovascular event risk by 50% compared to standard care alone.
Low-Dose Aspirin Shows Cardiovascular Benefits for High-Risk Type 2 Diabetes Patients
A preliminary study suggests adults with Type 2 diabetes and moderate-to-high cardiovascular risk who take low-dose aspirin experience significantly lower rates of heart attack, stroke, and death compared to non-users, though bleeding risks require careful consideration.
Glucotrack Innovates Diabetes Management with Implantable Glucose Monitor
Glucotrack Inc. is revolutionizing diabetes care with its fully implantable continuous blood glucose monitoring system, addressing key patient concerns and setting new standards for accuracy and convenience.
Glucotrack Unveils Revolutionary Continuous Blood Glucose Monitor Technology at Upcoming Webinar
Glucotrack is set to showcase its innovative Continuous Blood Glucose Monitor (CBGM) technology, offering a potential breakthrough in diabetes management with longer-lasting, real-time monitoring capabilities.
Glucotrack Advances Continuous Blood Glucose Monitor with First Human Trial Success
Glucotrack has completed a groundbreaking first-in-human study of its intravascular continuous blood glucose monitor, demonstrating safety and technical feasibility for insulin-dependent diabetes patients. The successful trial paves the way for a comprehensive long-term clinical evaluation.